Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)
Clinical trial NCT06390852 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06390852
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-21
- Primary completion
- 2023-04-24
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.